Your browser doesn't support javascript.
loading
Is there an association between serum 25-hydroxyvitamin D concentrations and obstructive sleep apnoea? A cross-sectional analysis of NHANES 2007-2008 data.
Li, Qingyuan; Yao, Jun; Duan, Ran; Feng, Tong.
Afiliação
  • Li Q; Clinical Medical College, Chengdu Medical College, Chengdu, People's Republic of China.
  • Yao J; Department of Respiratory and Critical Care Medicine,The First Affiliated Hospital of Chengdu Medical College, Chengdu, People's Republic of China.
  • Duan R; Laboratory of Geriatic Respiratory Diseases of Sichuan Higher Education Institute, Chengdu, People's Republic of China.
  • Feng T; Department of Respiratory and Critical Care Medicine,Guangyuan Central Hospital, Guangyuan, People's Republic of China.
BMJ Open ; 14(8): e085080, 2024 Aug 07.
Article em En | MEDLINE | ID: mdl-39117413
ABSTRACT

OBJECTIVES:

The study aimed to investigate the relationship between serum 25-hydroxyvitamin D (25(OH)D) concentrations and obstructive sleep apnoea (OSA) and to assess the confounding effect of body mass index (BMI) on this relationship.

DESIGN:

This was a cross-sectional analysis using data from the 2007-08 National Health and Nutrition Examination Survey (NHANES).

SETTING:

Data were sourced from NHANES, a continuous survey sponsored by the Centres for Disease Control and Prevention, covering residents from 15 urban areas in the United States of America(USA).

PARTICIPANTS:

The study included 4901 participants aged 16 years and older who had completed 25(OH)D data and responses to the OSA questionnaire. MAIN EXPOSURE

MEASURE:

Serum 25(OH)D concentrations were measured using liquid chromatography-tandem mass spectrometry. MAIN OUTCOME

MEASURE:

The primary outcome was the self-reported diagnosis of OSA from questionnaires.

RESULTS:

After adjusting for age, sex and race (model 1), a significant negative association was observed between 25(OH)D and OSA (ß=-3.21, 95% CI -6.17 to -0.26). However, this association was no longer significant after further adjustment for BMI (model 2) (ß=1.47, 95% CI -1.48, 4.42). In the fully adjusted model (model 3), there was no significant association between 25(OH)D and OSA (ß=0.92, 95% CI -1.93, 3.76). Subgroup analyses stratified by sex, age, race or BMI also revealed no significant associations between 25(OH)D and OSA.

CONCLUSIONS:

The study found no significant association between 25(OH)D and OSA. The observed correlation between lower levels of 25(OH)D and OSA may be due to confounding factors, such as higher BMI in the OSA group. Therefore, improving obesity management in OSA patients may be necessary to prevent 25(OH)D insufficiency. This underscores the importance of comprehensive management of both OSA and obesity to promote optimal health outcomes.
Assuntos
Palavras-chave

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Vitamina D / Índice de Massa Corporal / Inquéritos Nutricionais / Apneia Obstrutiva do Sono Limite: Adolescent / Adult / Aged / Female / Humans / Male / Middle aged País/Região como assunto: America do norte Idioma: En Revista: BMJ Open Ano de publicação: 2024 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Vitamina D / Índice de Massa Corporal / Inquéritos Nutricionais / Apneia Obstrutiva do Sono Limite: Adolescent / Adult / Aged / Female / Humans / Male / Middle aged País/Região como assunto: America do norte Idioma: En Revista: BMJ Open Ano de publicação: 2024 Tipo de documento: Article